LSL Pharma Group (TSXV:LSL) YoY EBITDA Growth : 140.00% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. LSL Pharma Group's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 140.00%.

LSL Pharma Group's EBITDA per Share for the three months ended in Jun. 2024 was C$0.00.

LSL Pharma Group YoY EBITDA Growth Historical Data

The historical data trend for LSL Pharma Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group YoY EBITDA Growth Chart

LSL Pharma Group Annual Data

Trend

Sep20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-12.50

-1,100.00

-2.86

LSL Pharma Group Quarterly Data
	Sep20	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial									37.50	96.15	-	108.82	140.00

LSL Pharma Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

LSL Pharma Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.072	-	-0.07)	/	\| -0.07 \|
=	-2.86 %

LSL Pharma Group's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(0.002	-	-0.005)	/	\| -0.005 \|
=	140.00 %

LSL Pharma Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

LSL Pharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5

Website

LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group Headlines

No Headlines